bpc 157 regulatory status canada BPC-157 Storage Temperature & Shelf Life: Complete Research Guide BPC-157 Canada | Maple Research

There is no oral or topical version of IGF-1 LR3 in research use

Thus, considering BPC 157/Parkinsons disease/Alzheimers disease, BPC 157 therapy was effective in Parkinsons disease models, and it counteracted parkinsonogenic neurotoxin MPTP-induced tremor, rigor, akinesia, and gastric lesions and counteracted mortality in mice, reserpine-induced akinesia, catalepsy, hypothermia, and catalepsy induced by neuroleptics or NOS-blocker L-NAME application [198,199,200]

doi: 10.3390/biomedicines9121752

Anti-Inflammatory Effects and Tissue Protection Research examines these peptides' interactions with inflammatory pathways and cellular protection mechanisms